Mechanism of action of a novel antivasospasm drug, HA1077.Takayuki Asano, Hisashi Hidaka, Ichiro Ikegaki et al.|Journal of Pharmacology and Experimental Therapeutics|1987Cited by 157
Vasodilator actions of HA1077 <i>in vitro</i> and <i>in vivo</i> putatively mediated by the inhibition of protein kinaseToshio Asano, Hisashi Hidaka, Takahito Suzuki et al.|British Journal of Pharmacology|1989Cited by 131
Neuroprotective properties of a protein kinase inhibitor against ischaemia‐induced neuronal damage in rats and gerbilsS. Satoh, Hisashi Hidaka, Ichiro Ikegaki et al.|British Journal of Pharmacology|1996Cited by 72
Blockade of intracellular actions of calcium may protect against ischaemic damage to the gerbil brainToshio Asano, Koshiro Sugita, Ichiro Ikegaki et al.|British Journal of Pharmacology|1991Cited by 47
The effects of an intracellular calcium antagonist HA 1077 on delayed cerebral vasospasm in dogsMasatoshi Shibuya, Hisashi Hidaka, Yasuhíro Suzuki et al.|Acta Neurochirurgica|1988Cited by 43